Dan Chisholm

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi request reprint Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use
    Dan Chisholm
    Evidence and Information for Policy, World Health Organisation, Geneva, Switzerland
    Drug Alcohol Rev 25:553-65. 2006
  2. pmc Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis
    Dan Chisholm
    Department of Health Systems Financing, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 86:542-51. 2008
  3. ncbi request reprint Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis
    Dan Chisholm
    Department of Health System Financing, Expenditure and Resource Allocation, World Health Organization, Geneva, Switzerland
    J Stud Alcohol 65:782-93. 2004
  4. ncbi request reprint Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis
    Dan Chisholm
    Department of Health System Financing, and Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland
    Epilepsia 46:751-9. 2005
  5. ncbi request reprint Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder
    Dan Chisholm
    Department of Health System Financing, Evidence and Information for Policy EIP, World Health Organization, 1211 Geneva, Switzerland
    Br J Psychiatry 187:559-67. 2005
  6. ncbi request reprint Cost of scaling up mental healthcare in low- and middle-income countries
    Dan Chisholm
    Department of Health Systems Financing HSF, World Health Organization, 1211 Geneva, Switzerland
    Br J Psychiatry 191:528-35. 2007
  7. ncbi request reprint Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions
    Dan Chisholm
    Department of Health System Financing, Expenditure and Resource Allocation, WHO, Geneva, Switzerland
    Br J Psychiatry 184:393-403. 2004
  8. ncbi request reprint Mental health system financing in developing countries: policy questions and research responses
    Dan Chisholm
    Epidemiol Psichiatr Soc 16:282-8. 2007
  9. doi request reprint Primary care treatment of epilepsy with phenobarbital in rural China: cost-outcome analysis from the WHO/ILAE/IBE global campaign against epilepsy demonstration project
    Ding Ding
    Department of Biostatistics snf Epidemiology, Institute of Neurology, Huashan Hospital, Fudan University, Shanghai, China
    Epilepsia 49:535-9. 2008
  10. ncbi request reprint Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use
    Perviz Asaria
    Kings Fund, London, UK
    Lancet 370:2044-53. 2007

Detail Information

Publications15

  1. ncbi request reprint Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use
    Dan Chisholm
    Evidence and Information for Policy, World Health Organisation, Geneva, Switzerland
    Drug Alcohol Rev 25:553-65. 2006
    ..These issues are the subject of the final section of this review...
  2. pmc Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis
    Dan Chisholm
    Department of Health Systems Financing, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 86:542-51. 2008
    ..Schizophrenia is a highly disabling disease and is costly to treat. We set out to establish what are the most cost-effective interventions applicable to developing regions and countries...
  3. ncbi request reprint Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis
    Dan Chisholm
    Department of Health System Financing, Expenditure and Resource Allocation, World Health Organization, Geneva, Switzerland
    J Stud Alcohol 65:782-93. 2004
    ..This study set out to estimate these costs and effects...
  4. ncbi request reprint Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis
    Dan Chisholm
    Department of Health System Financing, and Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland
    Epilepsia 46:751-9. 2005
    ..To establish the population-level costs and cost-effectiveness of first-line antiepileptic drug (AED) treatments for reducing the treatment gap in developing countries...
  5. ncbi request reprint Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder
    Dan Chisholm
    Department of Health System Financing, Evidence and Information for Policy EIP, World Health Organization, 1211 Geneva, Switzerland
    Br J Psychiatry 187:559-67. 2005
    ..Bipolar disorder has been ranked seventh among the worldwide causes of non-fatal disease burden...
  6. ncbi request reprint Cost of scaling up mental healthcare in low- and middle-income countries
    Dan Chisholm
    Department of Health Systems Financing HSF, World Health Organization, 1211 Geneva, Switzerland
    Br J Psychiatry 191:528-35. 2007
    ..No systematic attempt has been made to calculate the costs of scaling up mental health services in low- and middle-income countries...
  7. ncbi request reprint Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions
    Dan Chisholm
    Department of Health System Financing, Expenditure and Resource Allocation, WHO, Geneva, Switzerland
    Br J Psychiatry 184:393-403. 2004
    ..Aims To estimate the population-level cost-effectiveness of evidence-based depression interventions and their contribution towards reducing current burden...
  8. ncbi request reprint Mental health system financing in developing countries: policy questions and research responses
    Dan Chisholm
    Epidemiol Psichiatr Soc 16:282-8. 2007
    ....
  9. doi request reprint Primary care treatment of epilepsy with phenobarbital in rural China: cost-outcome analysis from the WHO/ILAE/IBE global campaign against epilepsy demonstration project
    Ding Ding
    Department of Biostatistics snf Epidemiology, Institute of Neurology, Huashan Hospital, Fudan University, Shanghai, China
    Epilepsia 49:535-9. 2008
  10. ncbi request reprint Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use
    Perviz Asaria
    Kings Fund, London, UK
    Lancet 370:2044-53. 2007
    ....
  11. ncbi request reprint Treatment and prevention of mental disorders in low-income and middle-income countries
    Vikram Patel
    Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
    Lancet 370:991-1005. 2007
    ..However, we recommend that policymakers should act on the available evidence to scale up effective and cost-effective treatments and preventive interventions for mental disorders...
  12. ncbi request reprint Resource utilisation for neuropsychiatric disorders in developing countries: a multinational Delphi consensus study
    Cleusa Ferri
    Section of Epidemiology, Institute of Psychiatry, King s College London, London, UK
    Soc Psychiatry Psychiatr Epidemiol 39:218-27. 2004
    ..Substantial information is now available at a global and regional level relating to the burden of mental disorders, yet hardly any international data are available on the resources that are needed to respond to this global burden...
  13. ncbi request reprint Towards a multi-criteria approach for priority setting: an application to Ghana
    Rob Baltussen
    Institute for Medical Technology Assessment, Erasmus Medical Center Rotterdam, The Netherlands
    Health Econ 15:689-96. 2006
    ..Many criteria have been proposed to guide priority setting in health, but their relative importance has not yet been determined in a way that allows a rank ordering of interventions...
  14. ncbi request reprint Keeping pace with assessing cost-effectiveness: economic efficiency and priority-setting in mental health
    Dan Chisholm
    Aust N Z J Psychiatry 39:645-7. 2005
  15. ncbi request reprint Costs, health effects and cost-effectiveness of alcohol and tobacco control strategies in Estonia
    Taavi Lai
    Department of Public Health, University of Tartu, Estonia
    Health Policy 84:75-88. 2007
    ..To assess the population-level costs, effects and cost-effectiveness of different alcohol and tobacco control strategies in Estonia...